These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

537 related items for PubMed ID: 25339396

  • 1. A study of genotyping for management of human papillomavirus-positive, cytology-negative cervical screening results.
    Schiffman M, Burk RD, Boyle S, Raine-Bennett T, Katki HA, Gage JC, Wentzensen N, Kornegay JR, Aldrich C, Tam T, Erlich H, Apple R, Befano B, Castle PE.
    J Clin Microbiol; 2015 Jan; 53(1):52-9. PubMed ID: 25339396
    [Abstract] [Full Text] [Related]

  • 2. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H, Canfell K, Gilham C, Sargent A, Roberts C, Desai M, Peto J.
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [Abstract] [Full Text] [Related]

  • 3. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE, Stoler MH, Wright TC, Sharma A, Wright TL, Behrens CM.
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [Abstract] [Full Text] [Related]

  • 4. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.
    Khan MJ, Castle PE, Lorincz AT, Wacholder S, Sherman M, Scott DR, Rush BB, Glass AG, Schiffman M.
    J Natl Cancer Inst; 2005 Jul 20; 97(14):1072-9. PubMed ID: 16030305
    [Abstract] [Full Text] [Related]

  • 5. Alinity m HR HPV Assay Fulfills Criteria for Human Papillomavirus Test Requirements in Cervical Cancer Screening Settings.
    Oštrbenk Valenčak A, Šterbenc A, Seme K, Poljak M.
    J Clin Microbiol; 2019 Dec 23; 58(1):. PubMed ID: 31666369
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The influence of type-specific human papillomavirus infections on the detection of cervical precancer and cancer: A population-based study of opportunistic cervical screening in the United States.
    Wheeler CM, Hunt WC, Cuzick J, Langsfeld E, Robertson M, Castle PE, New Mexico HPV Pap Registry Steering Committee.
    Int J Cancer; 2014 Aug 01; 135(3):624-34. PubMed ID: 24226935
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Risk of precancer determined by HPV genotype combinations in women with minor cytologic abnormalities.
    Gage JC, Schiffman M, Solomon D, Wheeler CM, Gravitt PE, Castle PE, Wentzensen N.
    Cancer Epidemiol Biomarkers Prev; 2013 Jun 01; 22(6):1095-101. PubMed ID: 23603204
    [Abstract] [Full Text] [Related]

  • 11. Type- and age-specific distribution of human papillomavirus in women attending cervical cancer screening in Finland.
    Leinonen MK, Anttila A, Malila N, Dillner J, Forslund O, Nieminen P.
    Br J Cancer; 2013 Nov 26; 109(11):2941-50. PubMed ID: 24136148
    [Abstract] [Full Text] [Related]

  • 12. Clinical evaluation of primary human papillomavirus (HPV) testing with extended HPV genotyping triage for cervical cancer screening: A pooled analysis of individual patient data from nine population-based cervical cancer screening studies from China.
    Dun C, Yuan M, Zhao X, Hu S, Arbyn M, Zhao F.
    Cancer Med; 2024 Jun 26; 13(11):e7316. PubMed ID: 38828559
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Assessment of the effectiveness of HPV16/18 infection referred for colposcopy in cervical cancer screening in Northwest of China.
    Zhang Q, Zhao M, Cao D, Wei X, Wang L, Li Y, Yang T, Zhao J, Pei M, Jia H, Cao S, Quan S, Yang X.
    J Med Virol; 2018 Jan 26; 90(1):165-171. PubMed ID: 28710863
    [Abstract] [Full Text] [Related]

  • 16. A study of HPV typing for the management of HPV-positive ASC-US cervical cytologic results.
    Schiffman M, Vaughan LM, Raine-Bennett TR, Castle PE, Katki HA, Gage JC, Fetterman B, Befano B, Wentzensen N.
    Gynecol Oncol; 2015 Sep 26; 138(3):573-8. PubMed ID: 26148763
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Risk-adapted primary HPV cervical cancer screening project in Wolfsburg, Germany--experience over 3 years.
    Luyten A, Scherbring S, Reinecke-Lüthge A, Braun BE, Pietralla M, Theiler K, Petry KU.
    J Clin Virol; 2009 Nov 26; 46 Suppl 3():S5-10. PubMed ID: 20129072
    [Abstract] [Full Text] [Related]

  • 19. Comparison of human papillomavirus genotyping and cytology triage, COMPACT Study: Design, methods and baseline results in 14 642 women.
    Aoyama-Kikawa S, Fujita H, Hanley SJB, Kasamo M, Kikuchi K, Torigoe T, Matsuno Y, Tamakoshi A, Sasaki T, Matsuura M, Kato Y, Dong P, Watari H, Saito T, Sengoku K, Sakuragi N.
    Cancer Sci; 2018 Jun 26; 109(6):2003-2012. PubMed ID: 29660849
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.